<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="146652">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01191346</url>
  </required_header>
  <id_info>
    <org_study_id>BTC-G1</org_study_id>
    <nct_id>NCT01191346</nct_id>
  </id_info>
  <brief_title>Radiation Planning Study for High Grade Brain Tumors</brief_title>
  <official_title>3T Versus 1.5T MR Approaches in Target Definition for Malignant Gliomas: Is There a Significant Difference in Tumor Extent and Radiation Treatment Volume?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cincinnati</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cincinnati</source>
  <brief_summary>
    <textblock>
      The purpose of this research study is to see if a higher strength MRI procedure provides
      better images to use in planning radiation treatments for patients with brain tumors in the
      future.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2010</start_date>
  <primary_completion_date type="Anticipated">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment volume</measure>
    <time_frame>1 year average</time_frame>
    <description>To assess the difference in treatment volume for radiation planning in gliomas as calculated using 1.5T versus 3T magnets</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">25</enrollment>
  <condition>High Grade Glioma</condition>
  <arm_group>
    <arm_group_label>3T MRI</arm_group_label>
    <description>Patients receiving 3T MRI</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>3T MRI</intervention_name>
    <description>3T MRI in addition to standard 1.5T MRI for treatment planning</description>
    <arm_group_label>3T MRI</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with high grade glioma planning to receive radiation therapy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histologically confirmed, newly diagnosed Grade III-IV glioma

          -  Planning to undergo radiation therapy

        Exclusion Criteria:

          -  Grade I or II glioma

          -  Patients unable to undergo MRI imaging
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jessica Guarnaschelli, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cincinnati</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>UC Cancer Center</last_name>
    <phone>513-584-7698</phone>
  </overall_contact>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2011</verification_date>
  <lastchanged_date>February 11, 2011</lastchanged_date>
  <firstreceived_date>August 25, 2010</firstreceived_date>
  <responsible_party>
    <name_title>University of Cincinnati</name_title>
    <organization>University of Cincinnati</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Glioma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
